• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全肝素化血液透析系统在绵羊中的成功应用。

Successful use of a totally heparin grafted hemodialysis system in sheep.

作者信息

Schmer G, Teng L N, Cole J J, Vizzo J E, Francisco M M, Scribner B H

出版信息

Trans Am Soc Artif Intern Organs. 1976;22:654-63.

PMID:951885
Abstract

A total of 33 totally heparin-grafted dialysis systems using HFAK Cordis Dow Models 3 and 4 have been compared to a total of 23 nongrafted systems. The comparison of deltap, flow rate, FBVL and macroscopic inspection showed highly significant differences in favor of the heparin-grafted systems. The antithrombogenic performance of the totally heparin-grafted systems is mainly due to a small leakage of heparin during the experiments. A minimum of 1.35 X 10(-8) Gm/cm2/min of heparin is sufficient to prevent clotting at the blood-polymer interface.

摘要

总共33个使用HFAK Cordis Dow型号3和4的全肝素化透析系统与23个未肝素化系统进行了比较。对跨膜压差、流速、纤维蛋白原消耗率(FBVL)和宏观检查的比较显示,全肝素化系统具有显著优势。全肝素化系统的抗血栓形成性能主要归因于实验过程中肝素的少量渗漏。最低1.35×10⁻⁸克/平方厘米/分钟的肝素足以防止血液与聚合物界面处形成凝血。

相似文献

1
Successful use of a totally heparin grafted hemodialysis system in sheep.全肝素化血液透析系统在绵羊中的成功应用。
Trans Am Soc Artif Intern Organs. 1976;22:654-63.
2
Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.使用Cordis Dow 3500中空纤维进行无肝素输注的血液透析。
Proc Clin Dial Transplant Forum. 1980;10:39-42.
3
Hollow fiber artificial kidney (hfak) dialysis without parenteral heparin.无胃肠外肝素的中空纤维人工肾(hfak)透析
Proc Clin Dial Transplant Forum. 1973;3:46-51.
4
Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.使用肝素涂层聚丙烯腈膜进行血液透析时的最佳抗凝策略。
Nephrol Dial Transplant. 2003 Oct;18(10):2097-104. doi: 10.1093/ndt/gfg272.
5
Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis.无肝素血液透析中血栓素B2血水平与早期系统凝血
ASAIO J. 1995 Apr-Jun;41(2):173-7.
6
Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique.采用频繁生理盐水冲洗、高血流量技术,使用铜仿中空纤维透析器进行无肝素血液透析。
Trans Am Soc Artif Intern Organs. 1985;31:590-4.
7
[Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].[低分子肝素预防血液透析体外循环血栓形成:具有更佳出血风险/有效性比的剂量标准化]
Acta Med Port. 1992 Feb;5(2):65-70.
8
Grafted synthetic sorbents for enhanced removal of toxic chemical agents from plasma.用于增强从血浆中去除有毒化学物质的移植合成吸附剂。
J Biomed Mater Res. 1983 Nov;17(6):993-1002. doi: 10.1002/jbm.820170609.
9
Heparin free dialysis: comparative data and results in high risk patients.无肝素透析:高危患者的比较数据及结果
Kidney Int. 1987 Jun;31(6):1351-5. doi: 10.1038/ki.1987.149.
10
A comparison of ticlopidine and heparin on hemodialysis in dogs.噻氯匹定与肝素在犬血液透析中的比较。
J Lab Clin Med. 1982 Dec;100(6):887-95.

引用本文的文献

1
Effect of heparin and heparin fractions on platelet aggregation.
J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.